The overall aim is to study the effects of a lifestyle intervention for young women who are pregnant
ID
Source
Brief title
Condition
- Glucose metabolism disorders (incl diabetes mellitus)
- Appetite and general nutritional disorders
- Pregnancy, labour, delivery and postpartum conditions
Synonym
Research involving
Sponsors and support
Intervention
Outcome measures
Primary outcome
Gestational weight gain within the IOM guidelines and the mean
weight-for-length z-score of the children at the age of 12 months.
Secondary outcome
- Postpartum weight retention: defined as weight at the beginning of the
pregnancy to the weight 6 months postpartum.
- Smoking cessation: measured with questionnaires, when smoking is present at
inclusion.
- Biochemical verification of tobacco use, if smoking is present at inclusion:
the amount of carbon monoxide (CO) in exhaled breath will be measured using a
CO monitor. Biochemical verification will also be done by measurement of urine
cotinine.
- Dietary habits: for several times, women will be asked to fill in a food
diary for seven days. Furthermore, the full-length version of the Three Factor
Eating Questionnaire (TFEQ) will be used to assess all of the characteristics
of dietary restrain.
- Physical activity habits: to measure their daily activity, women will be
asked to wear an accelerometer for seven full days for several times. The
Baecke questionnaire measures work, sport and leisure activities.
- Miscarriage: defined as loss of the fetus before the 20th week of pregnancy.
- Vitamin D status: vitamin D insufficiency is defined as a measurement < 50
nmol/L.
- Pregnancy complications: gestational diabetes mellitus, pregnancy induced
hypertension, preeclampsia.
- Childbirth complications: caesarean section, induction of labour, vacuum
extraction, postpartum haemorrhage, maternal hospital stay, shoulder dystocia.
- Dysmaturity and macrosomia: dysmaturity is defined as a birth weight below
the -2.5 standard deviation score (SDS) and macrosomia is defined as a birth
weight above the + 2.5 SDS of normal values for gestational age and gender.
- Prematurity: defined as birth before 37 weeks of gestation.
- Epigenetics: samples of the placenta and of the cord blood will be taken and
stored.
- Metabolic derangement: blood glucose leves, insulin resistancy (HOMA-IR),
dyslipidemia and liver enzymes. Furthermore, an oral glucose tolerance test
(OGTT) will be performed.
- Cardiovascular alterations: blood pressure, pulse wave velocity and
arteriovenous ratio by a retinal image will be measured.
- Endothelial-dependent vasodilatation of the child: in infants
endothelial-dependent vasodilatation will be measured by laser-Doppler combined
with iontophoresis on response to acetylcholine and nitroprusside.
- Microbial flora: in mothers, samples of the faeces, throat and vaginal swabs
will be taken. In children, samples of the faeces and throat swabs will be
taken. The samples will be stored at -80*C until analysis.
- Feeding and activity pattern of the child: using a diary parents will report
the feeding and activity pattern of their child.
- Metabolic derangement of the child: bloodglucose, insulin levels and lipid
profile will be determined.
- Lung function of the child: functional residual capacity, lung clearance
index, airway resistance and tidal breathing indices will be measured.
- Breast milk composition (if the mother breastfeed the child): breast milk
will be collected by using an electric breast pump. The samples will be stored
at -80*C until analysis.
- Body composition: the two-compartment model will be applied.
Background summary
The negative perinatal consequences of obesity and smoking during and after
pregnancy for mothers and children are significant. Examples of these negative
consequences are a higher risk of dysmaturity, prematurity, gestational
diabetes mellitus, pregnancy induced hypertension and caesarean delivery.
Furthermore, the offspring has a higher chance on asthma, obesity and metabolic
abberations in childhood, progressing in adulthood. Therefore, it is important
to break the vicious circle of transferring harmful lifestyle influences from
generation to generation. However, it is unknown what the right time span is in
the period around pregnancy to start with a lifestyle intervention. Previous
studies have shown that a lifestyle intervention started after approximately
12-16 weeks of gestational age is insufficient to improve perinatal outcomes.
For the effecitiveness of a lifestyle intervention started before 12 weeks of
gestational age is insufficient evidence available. Therefore, we offer women
who are pregnant before 12 weeks of gestational age a lifestyle intervention
and we evaluate the effect of the lifestyle intervention in the current study.
Study objective
The overall aim is to study the effects of a lifestyle intervention for young
women who are pregnant <= 12 weeks of gestational age and have a high risk on
perinatal morbidity because of prepregnancy overweight or obesity and, if
applicable, smoking on weight, lifestyle habits, perinatal morbidity, maternal
body composition, epigenetics, breast milk composition, metabolic and
cardiovascular markers in mother and child, microbial flora of mother and child
and lung function of the child.
Study design
Non-randomised intervention study with a pre-postdesign. All women included in
this study will participate in the lifestyle intervention.
Intervention
The investigational treatment consists of a lifestyle intervention and will
directed towards a healthy diet, adequate physical activity and, if applicable,
smoking cessation. The program will start with a personal screening of the
women at the website of Slimmer Zwanger. The women receive information about
their unhealthy and healthy lifestyle habits, making visible with a figure and
supporting text. Thereafter, the coaching part of Slimmer Zwanger will start.
Through digital posts, women will get tips, tricks, rewards and recipes for
healthy meals. The advices are customised according to the results of the
personal screening and are offered at least three times a week. The lifestyle
intervention regarding a healthy diet and adequate physical activity can
consist of different components. First, women can participate in the program of
the Centre for Obesity and eating disorders Europe (CO-EUR). CO-EUR is a
second-line mental health institution and is specialised in treatment of
patients with obesity and eating disorders and their related comorbidities. The
treatment of CO-EUR is based on evidence based treatment methods. The short
program (4 months of duration) will be offered to the women participating in
this study. Furthermore, the lifestyle intervention will consist of specific
lifestyle advices during different phases of their life (during pregnancy and
postpartum). The lifestyle intervention targeted at overweight and obesity is
based on the recommendations of the CBO guideline *Diagnostics and treatment of
obesity in adults and children* and consists of a structured lifestyle program
targeted at: - Changing the dietary pattern; - Stimulating physical activity of
moderate intensity; - Self-monitoring; - Involvement of the partner. Each women
will have her personal lifestyle coach. This personal coach will have an
overview over the lifestyle intervention and guide the women through their
personal program. Moreover, this personal coach is involved with the smoking
cessation coaching if smoking is present at inclusion. Smoking cessation will
be stimulated by coaching of the website of Slimmer Zwanger. Moreover, the
personal coach will stimulate the women to stop smoking by direct feedback by
use of carbon monoxide (CO)-measurements. The CO-gauger will show the CO
concentration in the blood of the foetus as well.
Study burden and risks
For the women, there are no associated risks in this study and the intervention
is non-invasive. The lifestyle intervention will be performed according to the
current guidelines and are under stringent supervision. Women will visit the
hospital, CO-EUR or sport activities on a regular basis. This requires time and
effort of the women. To limit the burden as much as possible, the activities
will be adapted as much as possible to work and other activities of the women.
Participating women will attend the clinic for 11-12 extra visits in order to
improve lifestyle, this will take around 8 hours. Moreover, they will
participate in a physical activity program, 1 time a week (1 hour). Women
should adapt their lifestyle in order to achieve a healthier lifestyle. This
will entail a certain degree of effort. Subjects are more likely to benefit
from this research. The intervention could have beneficial effects for the
study population like improving their health status and inducing less pregnancy
and delivery complications. Finally, at the long term the global public health
will benefit as well. Data that will be collected, consisted of questionnaires
(TFEQ, EQ-5D-5L, Baecke questionnaire and smoking behaviour), measurements of
weight, anthropometry, blood pressure, CO measurements (11-12 times), body
composition (3 times), glucose, insulin, lipid profile and liver enzymes (6
times), OGTT (3 times), PWV and retinal image (5 times) and urine cotinine (6
times) in the mother. Furthermore, samples of microbial flora (faeces, vaginal
swab and throat swab) will be collected each 3 months and samples of breast
milk will be collected 1 time. The health risks of most of the measurements are
considered as negligible, since the methods are routinely used in both research
and in clinical practice. Sampling of a vaginal swab and breast milk will take
place. Taking these samples are considered to be minimal invasive, but can
bound up with some burdens for the women.
The intervention and measurements will take place mainly in the mother during
the study. However, a part of the intervention is targeted on the child and a
couple of measurements will be executed in the children. The part of the
intervention that is targeted on the child will exists of advices to the
parents among nutrition and physical activity for their child. Examples of
these advices are the introduction of solid food and sufficient physical
activity. In usual care, these advices are already implemented in the child
well being centers. However, these advices will be reinforced within the
lifestyle intervention. The child will not be exposed to risks. In which way
parents adhere to these advices will be monitored by a feeding and activity
diary. Moreover, in all children a couple of measurements will be executed. In
general, these measurements are considered as a minimal burden and the health
risks are negligible. In the children, data collection will consist of 2 times
a blood sample (of which 1 time is taken from the cord blood), measurement of
the endothelial-dependent vasodilatation and lung function and collection of
the microbial flora (faeces and throat swab) for 2 times. We believe that the
burden of the measurements will be compensated by the social interest of the
outcome of these measurements. With these measurements we can study the effects
of the degree of gestational weight gain and/or smoking reduction on the health
of the mother and child. Moreover, with the data that will be collected, more
insight into the causes and relationships between the transition of harmful
lifestyle influences and the development of non-communicable diseases will be
derived. The lifestyle intervention is set up in that way, that implementation
in usual care would be very easy. When the lifestyle intervention will turn out
to be effective, this can be easy implemented in the already existing health
care. With this in mind, this study will contribute to the global public
health. Namely, not only the health of the mother will improve, but also the
health of the child will be guaranteed by an intervention that break the
vicious circle of transferring harmful lifestyle influences from generation to
generation.
P. Debyelaan 25
Maastricht 6229HX
NL
P. Debyelaan 25
Maastricht 6229HX
NL
Listed location countries
Age
Inclusion criteria
- Pregnant women with a gestational age <= 12 weeks + 6 days;
- Aged 18-40 years;
- Prepregnancy overweight/obesity (BMI >= 25.0 kg/m2). Self-reported prepregnancy weight and measured height at baseline will be used to calculate prepregnancy BMI.
Exclusion criteria
- Haemodynamically significant heart disease;
- Restrictive lung disease;
- Congenital metabolic disease;
- Mentally retarded;
- Bariatric surgery;
- Diabetes type II, dependent on medicine.
Design
Recruitment
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
Register | ID |
---|---|
CCMO | NL63016.068.17 |